Terumo Corporation (TYO:4543)
1,962.00
-35.00 (-1.75%)
Feb 20, 2026, 3:30 PM JST
Terumo Revenue
Terumo had revenue of 296.63B JPY in the quarter ending December 31, 2025, with 12.55% growth. This brings the company's revenue in the last twelve months to 1.10T, up 8.34% year-over-year. In the fiscal year ending March 31, 2025, Terumo had annual revenue of 1.04T with 12.40% growth.
Revenue (ttm)
1.10T
Revenue Growth
+8.34%
P/S Ratio
2.64
Revenue / Employee
35.81M
Employees
30,591
Market Cap
2.89T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.04T | 114.31B | 12.40% |
| Mar 31, 2024 | 921.86B | 101.65B | 12.39% |
| Mar 31, 2023 | 820.21B | 116.91B | 16.62% |
| Mar 31, 2022 | 703.30B | 89.46B | 14.57% |
| Mar 31, 2021 | 613.84B | -15.06B | -2.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Olympus | 987.51B |
| HOYA Corporation | 915.21B |
| Ship Healthcare Holdings | 708.37B |
| Nipro | 652.61B |
| Sysmex | 502.95B |
| Asahi Intecc | 129.80B |
| Menicon | 123.91B |
| JINS HOLDINGS | 100.15B |
Terumo News
- 6 days ago - Terumo Corp (TRUMF) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic Acquisitions ... - GuruFocus
- 6 days ago - Q3 2026 Terumo Corp Earnings Call Transcript - GuruFocus
- 9 days ago - Terumo reports Q3 results - Seeking Alpha
- 10 days ago - Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Terumo Reports Higher Earnings In 9-Month; Raises FY26 Guidance - Nasdaq
- 5 weeks ago - Terumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Terumo Launches SurTract Safety Syringe In US Market - Nasdaq
- 3 months ago - Q2 2026 Terumo Corp Earnings Presentation Transcript - GuruFocus